These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 26352001)

  • 1. Role of adenoviruses in obesity.
    Voss JD; Atkinson RL; Dhurandhar NV
    Rev Med Virol; 2015 Nov; 25(6):379-87. PubMed ID: 26352001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tracking Study About Adenovirus 36 Infection: Increase of Adiposity.
    Park S; Kim J; Shin HJ; Hong YM; Sheen YH; Park HL; Jeon HJ; Ahn SY; Nam JH
    J Microbiol Biotechnol; 2015 Dec; 25(12):2169-72. PubMed ID: 26428735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-five years of research about adipogenic adenoviruses: A systematic review.
    Akheruzzaman M; Hegde V; Dhurandhar NV
    Obes Rev; 2019 Apr; 20(4):499-509. PubMed ID: 30562840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obesity-independent association of human adenovirus Ad37 seropositivity with nonalcoholic fatty liver disease.
    Trovato GM; Martines GF; Pirri C; Trovato FM; Castro A; Garozzo A; Catalano D
    J Clin Gastroenterol; 2012 Jul; 46(6):e46-54. PubMed ID: 22476041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate identification of neutralizing antibodies to adenovirus Ad36, -a putative contributor of obesity in humans.
    Dubuisson O; Day RS; Dhurandhar NV
    J Diabetes Complications; 2015; 29(1):83-7. PubMed ID: 25312598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human obesity relationship with Ad36 adenovirus and insulin resistance.
    Trovato GM; Castro A; Tonzuso A; Garozzo A; Martines GF; Pirri C; Trovato F; Catalano D
    Int J Obes (Lond); 2009 Dec; 33(12):1402-9. PubMed ID: 19786969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36.
    Na HN; Nam JH
    Int J Obes (Lond); 2014 Nov; 38(11):1470-4. PubMed ID: 24614097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies.
    Yamada T; Hara K; Kadowaki T
    PLoS One; 2012; 7(7):e42031. PubMed ID: 22848697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease.
    Trovato GM; Martines GF; Garozzo A; Tonzuso A; Timpanaro R; Pirri C; Trovato FM; Catalano D
    Liver Int; 2010 Feb; 30(2):184-90. PubMed ID: 19840251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E4orf1: a novel ligand that improves glucose disposal in cell culture.
    Dhurandhar EJ; Dubuisson O; Mashtalir N; Krishnapuram R; Hegde V; Dhurandhar NV
    PLoS One; 2011; 6(8):e23394. PubMed ID: 21886789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Template to improve glycemic control without reducing adiposity or dietary fat.
    Krishnapuram R; Dhurandhar EJ; Dubuisson O; Kirk-Ballard H; Bajpeyi S; Butte N; Sothern MS; Larsen-Meyer E; Chalew S; Bennett B; Gupta AK; Greenway FL; Johnson W; Brashear M; Reinhart G; Rankinen T; Bouchard C; Cefalu WT; Ye J; Javier R; Zuberi A; Dhurandhar NV
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E779-89. PubMed ID: 21266671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus 36 attenuates weight loss from exercise but improves glycemic control by increasing mitochondrial activity in the liver.
    Na HN; Hong YM; Ye MB; Park S; Kim IB; Nam JH
    PLoS One; 2014; 9(12):e114534. PubMed ID: 25479564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a standard protocol for quantitative polymerase chain reaction to detect adenovirus 36, which is associated with obesity.
    Hwang KA; Park S; Ahn JH; Nam JH
    Acta Virol; 2018; 62(4):350-359. PubMed ID: 30472864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term changes in adiposity and glycemic control are associated with past adenovirus infection.
    Lin WY; Dubuisson O; Rubicz R; Liu N; Allison DB; Curran JE; Comuzzie AG; Blangero J; Leach CT; Göring H; Dhurandhar NV
    Diabetes Care; 2013 Mar; 36(3):701-7. PubMed ID: 23160725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation.
    Na HN; Nam JH
    J Infect Dis; 2012 Mar; 205(6):914-22. PubMed ID: 22275403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenovirus 36 improves glycemic control and markers of Alzheimer's disease pathogenesis.
    Hegde V; Vijayan M; Kumar S; Akheruzzaman M; Sawant N; Dhurandhar NV; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2019 Nov; 1865(11):165531. PubMed ID: 31398466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral Infection and Obesity: Current Status and Future Prospective.
    Sohrab SS; Kamal MA; Atkinson RL; Alawi MM; Azhar EI
    Curr Drug Metab; 2017; 18(9):798-807. PubMed ID: 28093994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serological data analyses show that adenovirus 36 infection is associated with obesity: a meta-analysis involving 5739 subjects.
    Shang Q; Wang H; Song Y; Wei L; Lavebratt C; Zhang F; Gu H
    Obesity (Silver Spring); 2014 Mar; 22(3):895-900. PubMed ID: 23804409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus 36 and obesity in children and adolescents.
    Gabbert C; Donohue M; Arnold J; Schwimmer JB
    Pediatrics; 2010 Oct; 126(4):721-6. PubMed ID: 20855385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance.
    Trovato GM; Martines GF; Trovato FM; Pirri C; Pace P; Garozzo A; Castro A; Catalano D
    Dig Dis Sci; 2012 Feb; 57(2):535-44. PubMed ID: 21953137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.